Cargando…
Drug-Induced Liver Injury After Soy Protein Supplement Use
Drug-induced liver injury (DILI) is an important and often elusive cause of iatrogenic hepatic injury which complicates its recognition and treatment. We describe a rare case of severe liver injury in a previously healthy individual associated with a commonly used and reportedly safe soy protein pow...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Gastroenterology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435388/ https://www.ncbi.nlm.nih.gov/pubmed/26157956 http://dx.doi.org/10.14309/crj.2015.47 |
_version_ | 1782371914461741056 |
---|---|
author | Pillai, Ajish Thapar, Manish |
author_facet | Pillai, Ajish Thapar, Manish |
author_sort | Pillai, Ajish |
collection | PubMed |
description | Drug-induced liver injury (DILI) is an important and often elusive cause of iatrogenic hepatic injury which complicates its recognition and treatment. We describe a rare case of severe liver injury in a previously healthy individual associated with a commonly used and reportedly safe soy protein powder supplement. Discontinuation of the supplements and initiation of ursodeoxycholic acid provided symptomatic relief, decreased pruritus, and resulted in a resolution of hepatic panel labs. |
format | Online Article Text |
id | pubmed-4435388 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | American College of Gastroenterology |
record_format | MEDLINE/PubMed |
spelling | pubmed-44353882015-07-08 Drug-Induced Liver Injury After Soy Protein Supplement Use Pillai, Ajish Thapar, Manish ACG Case Rep J Case Report Drug-induced liver injury (DILI) is an important and often elusive cause of iatrogenic hepatic injury which complicates its recognition and treatment. We describe a rare case of severe liver injury in a previously healthy individual associated with a commonly used and reportedly safe soy protein powder supplement. Discontinuation of the supplements and initiation of ursodeoxycholic acid provided symptomatic relief, decreased pruritus, and resulted in a resolution of hepatic panel labs. American College of Gastroenterology 2015-04-10 /pmc/articles/PMC4435388/ /pubmed/26157956 http://dx.doi.org/10.14309/crj.2015.47 Text en Copyright © Pillai et al. This is an open-access article. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. |
spellingShingle | Case Report Pillai, Ajish Thapar, Manish Drug-Induced Liver Injury After Soy Protein Supplement Use |
title | Drug-Induced Liver Injury After Soy Protein Supplement Use |
title_full | Drug-Induced Liver Injury After Soy Protein Supplement Use |
title_fullStr | Drug-Induced Liver Injury After Soy Protein Supplement Use |
title_full_unstemmed | Drug-Induced Liver Injury After Soy Protein Supplement Use |
title_short | Drug-Induced Liver Injury After Soy Protein Supplement Use |
title_sort | drug-induced liver injury after soy protein supplement use |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435388/ https://www.ncbi.nlm.nih.gov/pubmed/26157956 http://dx.doi.org/10.14309/crj.2015.47 |
work_keys_str_mv | AT pillaiajish druginducedliverinjuryaftersoyproteinsupplementuse AT thaparmanish druginducedliverinjuryaftersoyproteinsupplementuse |